← 返回

工程化热诱导巨噬细胞的促炎极化在癌症免疫治疗中重编程肿瘤免疫微环境

英文原题:Proinflammatory polarization of engineered heat-inducible macrophages reprogram the tumor immune microenvironment during cancer immunotherapy.

查看英文原题

Proinflammatory polarization of engineered heat-inducible macrophages reprogram the tumor immune microenvironment during cancer immunotherapy.

PubMed 2024/03/15(内容时间) Nat Commun Q1 · IF 18.1(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

基于巨噬细胞的过继性细胞疗法的成功在很大程度上受限于免疫抑制性肿瘤微环境(TME)中从替代激活(M2样)表型向经典激活(M1样)表型极化不良。在此,我们展示了一种带有热诱导基因开关的工程化巨噬细胞(eMac),在小鼠模型中,该细胞能够响应轻度温度升高,同时诱导过继转移的eMac自身极化以及肿瘤相关巨噬细胞的再极化。eMac在TME中局部区域产生促炎细胞因子,不仅诱导巨噬细胞强烈极化为经典激活表型,还确保避免了全身给予促炎细胞因子时典型的副作用。我们还提出了一种可穿戴加温装置,适用于人类患者,并可通过智能手机远程控制。总之,我们的工作代表了一种安全有效的过继转移免疫治疗方法,具有人类转化潜力。

展开英文摘要原文

The success of macrophage-based adoptive cell therapy is largely constrained by poor polarization from alternatively activated (M2-like) to classically activated (M1-like) phenotype in the immunosuppressive tumor microenvironment (TME).

Here, we show that the engineered macrophage (eMac) with a heat-inducible genetic switch can induce both self-polarization of adoptively transferred eMac and re-polarization of tumour-associated macrophages in response to mild temperature elevation in a mouse model. The locoregional production of proinflammatory cytokines by eMac in the TME dose not only induces the strong polarization of macrophages into a classically activated phenotype, but also ensures that the side effects typical for systemically administrate proinflammatory cytokines are avoided.

We also present a wearable warming device which is adaptable for human patients and can be remotely controlled by a smartphone. In summary, our work represents a safe and efficient adoptive transfer immunotherapy method with potential for human translation.

论文信息

作者
Xue Y、Yan X、Li D、Dong S、Ping Y
第一作者单位
Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, 310016, China.China
通讯作者单位
Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, 310016, China. pingy@zju.edu.cn.China
期刊
Nature communications2024 Mar 15
原文标识
PubMed 38491004 · DOI 10.1038/s41467-024-46210-1